Brachial plexopathy following use of recombinant human BMP-2 for treatment of atrophic delayed union of the clavicle

John R. Matthews, David S. Margolis, Eileen Wu, Lisa M Truchan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Case: Although recombinant human bone morphogenetic protein-2 (rhBMP-2) is approved for treatment of open tibial fractures and anterior lumbar interbody fusion, off-label use has been associated with complications such as local inflammation, osteolysis, and dysphagia. This case report describes a patient treated with rhBMP-2 for an atrophic delayed union of a clavicular fracture who subsequently developed a profound motor and sensory brachial plexopathy. Conclusion: Use of rhBMP-2 near peripheral nerves may cause neuropathy. This should be considered prior to its use in surgical sites with peripheral nerves in proximity.

Original languageEnglish (US)
Article numbere81
JournalJBJS Case Connector
Volume5
Issue number3
DOIs
StatePublished - Jul 8 2015

Fingerprint

Brachial Plexus Neuropathies
Clavicle
Peripheral Nerves
Off-Label Use
Tibial Fractures
Open Fractures
Osteolysis
Deglutition Disorders
Therapeutics
Inflammation
recombinant human bone morphogenetic protein-2

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Brachial plexopathy following use of recombinant human BMP-2 for treatment of atrophic delayed union of the clavicle. / Matthews, John R.; Margolis, David S.; Wu, Eileen; Truchan, Lisa M.

In: JBJS Case Connector, Vol. 5, No. 3, e81, 08.07.2015.

Research output: Contribution to journalArticle

@article{edd406173d504c35b59cccd65ed1d4b4,
title = "Brachial plexopathy following use of recombinant human BMP-2 for treatment of atrophic delayed union of the clavicle",
abstract = "Case: Although recombinant human bone morphogenetic protein-2 (rhBMP-2) is approved for treatment of open tibial fractures and anterior lumbar interbody fusion, off-label use has been associated with complications such as local inflammation, osteolysis, and dysphagia. This case report describes a patient treated with rhBMP-2 for an atrophic delayed union of a clavicular fracture who subsequently developed a profound motor and sensory brachial plexopathy. Conclusion: Use of rhBMP-2 near peripheral nerves may cause neuropathy. This should be considered prior to its use in surgical sites with peripheral nerves in proximity.",
author = "Matthews, {John R.} and Margolis, {David S.} and Eileen Wu and Truchan, {Lisa M}",
year = "2015",
month = "7",
day = "8",
doi = "10.2106/JBJS.CC.N.00187",
language = "English (US)",
volume = "5",
journal = "JBJS Case Connector",
issn = "2160-3251",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Brachial plexopathy following use of recombinant human BMP-2 for treatment of atrophic delayed union of the clavicle

AU - Matthews, John R.

AU - Margolis, David S.

AU - Wu, Eileen

AU - Truchan, Lisa M

PY - 2015/7/8

Y1 - 2015/7/8

N2 - Case: Although recombinant human bone morphogenetic protein-2 (rhBMP-2) is approved for treatment of open tibial fractures and anterior lumbar interbody fusion, off-label use has been associated with complications such as local inflammation, osteolysis, and dysphagia. This case report describes a patient treated with rhBMP-2 for an atrophic delayed union of a clavicular fracture who subsequently developed a profound motor and sensory brachial plexopathy. Conclusion: Use of rhBMP-2 near peripheral nerves may cause neuropathy. This should be considered prior to its use in surgical sites with peripheral nerves in proximity.

AB - Case: Although recombinant human bone morphogenetic protein-2 (rhBMP-2) is approved for treatment of open tibial fractures and anterior lumbar interbody fusion, off-label use has been associated with complications such as local inflammation, osteolysis, and dysphagia. This case report describes a patient treated with rhBMP-2 for an atrophic delayed union of a clavicular fracture who subsequently developed a profound motor and sensory brachial plexopathy. Conclusion: Use of rhBMP-2 near peripheral nerves may cause neuropathy. This should be considered prior to its use in surgical sites with peripheral nerves in proximity.

UR - http://www.scopus.com/inward/record.url?scp=84977123305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977123305&partnerID=8YFLogxK

U2 - 10.2106/JBJS.CC.N.00187

DO - 10.2106/JBJS.CC.N.00187

M3 - Article

VL - 5

JO - JBJS Case Connector

JF - JBJS Case Connector

SN - 2160-3251

IS - 3

M1 - e81

ER -